InvestorsHub Logo

$Pistol Pete$

07/26/17 11:09 AM

#72160 RE: Triple9 #72159

$PMCB Austrianova featured as one of the top GMP cell banking companies in a new report released this month entitled "GMP Cell Banking Services Market: Global Industry Analysis and Forecast, 2017–2025”

http://m.digitaljournal.com/pr/3425467

ziarfj

07/26/17 11:12 AM

#72161 RE: Triple9 #72159

Totally agree and good points. Until the news is mainstream e.g. IND or at least the ETF, there is a lack of visibility and thus the low volume. Now is time to load up in prep for launch! All the pieces are falling into place.

TheBestInvest

07/26/17 12:05 PM

#72172 RE: Triple9 #72159

Great Post!

I think her appointment indicates we may have multiple trials going on at once... I really think (and hope) PMCB has a PRE IND for Diabetes shortly after our IND is submitted for PC trials.

Our technology will be able to work on all tumors not just PC... we will need trials for each type of cancer treatment. They will move quickly once we show success on the toughest to treat- Pancreatic Cancer.

Tajim

07/26/17 12:22 PM

#72175 RE: Triple9 #72159

The real question is why would she leave such a prestigious position to join Pharmacyte? This has to be a big deal in my opinion.

1234jklm

07/26/17 1:47 PM

#72199 RE: Triple9 #72159

Dr Sher must believe we have a...very....valuable...technology to take this position